Report overview
The purpose of hepatitis tests is to screen for and diagnose hepatitis, evaluate the liver, and to determine the underlying cause of hepatitis
Common hepatitis tests include Enzyme-linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDT), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), etc.
This report contains market size and forecasts of Hepatitis Testing Diagnosis in global, including the following market information:
Global Hepatitis Testing Diagnosis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hepatitis Testing Diagnosis Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hepatitis Testing Diagnosis companies in 2021 (%)
The global Hepatitis Testing Diagnosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Enzyme-linked Immunosorbent Assay (ELISA) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis Testing Diagnosis include F. Hoffmann-La Roche, Abbott Laboratories, Siemens Healthineers AG, Bio-Rad Laboratories, Danaher Corporation, QIAGEN, BioMerieux SA, DiaSorin S.P.A. and Ortho Clinical Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis Testing Diagnosis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis Testing Diagnosis Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hepatitis Testing Diagnosis Market Segment Percentages, by Type, 2021 (%)
Enzyme-linked Immunosorbent Assay (ELISA)
Rapid Diagnostic Tests (RDT)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others
Global Hepatitis Testing Diagnosis Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hepatitis Testing Diagnosis Market Segment Percentages, by Application, 2021 (%)
Hospital
Blood Banks
Other
Global Hepatitis Testing Diagnosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hepatitis Testing Diagnosis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis Testing Diagnosis revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hepatitis Testing Diagnosis revenues share in global market, 2021 (%)
Key companies Hepatitis Testing Diagnosis sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hepatitis Testing Diagnosis sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche
Abbott Laboratories
Siemens Healthineers AG
Bio-Rad Laboratories
Danaher Corporation
QIAGEN
BioMerieux SA
DiaSorin S.P.A.
Ortho Clinical Diagnostics
MedMira Inc
Fujirebio
Grifols
Orasure Technologies
GenMark Diagnostics
Vela Diagnostics
Epitope Diagnostics
Trivitron Healthcare
Meril Life Sciences
geneOmbio Technologies
Molbio Diagnostics
